FLT3 internal tandem duplication (FLT3/ITD) occurs in approximately 10% to 20% of pediatric AML cases and conveys a poor prognosis, which is favorably modified by the presence of a low allelic ratio or concomitant NPM1 mutations. The gene discussed is NPM1; the disease is acute myeloid leukemia.